↓ Skip to main content

Outcomes of therapy with venetoclax combined with a hypomethylating agent in favorable‐risk acute myeloid leukemia

Overview of attention for article published in American Journal of Hematology, December 2020
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (62nd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (51st percentile)

Mentioned by

policy
1 policy source
twitter
1 X user

Readers on

mendeley
27 Mendeley